<?xml version="1.0" encoding="UTF-8" ?>








    
    
    
    













        
            
            
        <!-- FT CACHE --> 

<?xml-stylesheet title="XSL_formatting" type="text/xsl" href="http://www.ft.com/FTCOM/XSL/styleRSSFeed.xsl"?><rss xmlns:java="java" xmlns:ft="http://www.ft.com/FTRSSExtensions" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><atom:link type="application/xml" rel="self" href="http://www.ft.com/rss/mergermarket"/><title>FT.com - Mergermarket</title><link>/mergermarket</link><ft:rsslink>http://www.ft.com/rss/mergermarket</ft:rsslink><description>FT.com - Mergermarket</description><language>en</language><copyright>© Copyright The Financial Times Ltd 2012. "FT" and "Financial Times" are trademarks of the Financial Times. See http://www.ft.com/servicestools/help/terms#legal1 for the terms and conditions of reuse.</copyright><webMaster>client.support@ft.com (Client Support)</webMaster><pubDate>Tue, 14 Feb 2012 23:31:35 +0000</pubDate><lastBuildDate>Wed, 15 Feb 2012 01:34:22 +0000</lastBuildDate><category>Newspapers</category><ttl>15</ttl><image><url>http://news.ft.com/cms/d1f3ce1a-6bbe-11da-bb53-0000779e2340.gif</url><title>FT.com - Mergermarket</title><link>/mergermarket</link></image><rating>(PICS-1.1 "http://www.classify.org/safesurf/" L gen true for "http://www.ft.com/" r (SS~~000 1))</rating><item><title>Novartis' Gilenya still deemed safe despite EMA-initiated review of deaths</title><link>http://www.ft.com/cms/s/2/5de3bae4-5762-11e1-869b-00144feabdc0.html?ftcamp=rss</link><guid>http://www.ft.com/cms/s/2/5de3bae4-5762-11e1-869b-00144feabdc0.html?ftcamp=rss</guid><description>Neurologists await more information before changing prescriptions. by BioPharm Insight
</description><pubDate>Tue, 14 Feb 2012 23:31:35 +0000</pubDate><ft:uid>5de3bae4-5762-11e1-869b-00144feabdc0</ft:uid></item><item><title>Georgia Gulf deadline key to deciphering Westlake strategy</title><link>http://www.ft.com/cms/s/2/a294b1b6-5424-11e1-8d12-00144feabdc0.html?ftcamp=rss</link><guid>http://www.ft.com/cms/s/2/a294b1b6-5424-11e1-8d12-00144feabdc0.html?ftcamp=rss</guid><description>Limited rival bidder interest, Westlake has most synergies. by dealReporter
</description><pubDate>Fri, 10 Feb 2012 20:40:26 +0000</pubDate><ft:uid>a294b1b6-5424-11e1-8d12-00144feabdc0</ft:uid></item><item><title>Adco Global in early stages of sale process</title><link>http://www.ft.com/cms/s/2/a580e3e0-5424-11e1-8d12-00144feabdc0.html?ftcamp=rss</link><guid>http://www.ft.com/cms/s/2/a580e3e0-5424-11e1-8d12-00144feabdc0.html?ftcamp=rss</guid><description>Source says specialty adhesives firm generates USD 50m EBITDA. by mergermarket
</description><pubDate>Fri, 10 Feb 2012 20:40:10 +0000</pubDate><ft:uid>a580e3e0-5424-11e1-8d12-00144feabdc0</ft:uid></item><item><title>Pharma majors' multiple sclerosis drugs safe from EU competition for several years</title><link>http://www.ft.com/cms/s/2/c319e28e-4ea3-11e1-ada2-00144feabdc0.html?ftcamp=rss</link><guid>http://www.ft.com/cms/s/2/c319e28e-4ea3-11e1-ada2-00144feabdc0.html?ftcamp=rss</guid><description>Tough EMA requirements give Biogen, Merck and Bayer up to five years' breathing space. b
y BioPharm Insight
</description><pubDate>Fri, 3 Feb 2012 20:45:21 +0000</pubDate><ft:uid>c319e28e-4ea3-11e1-ada2-00144feabdc0</ft:uid></item><item><title>Yahoo: Alibaba remains in complicated split talks</title><link>http://www.ft.com/cms/s/2/0548a850-4c26-11e1-bd09-00144feabdc0.html?ftcamp=rss</link><guid>http://www.ft.com/cms/s/2/0548a850-4c26-11e1-bd09-00144feabdc0.html?ftcamp=rss</guid><description>Cash-rich transaction doable, but complicated. by dealReporter
</description><pubDate>Tue, 31 Jan 2012 16:25:23 +0000</pubDate><ft:uid>0548a850-4c26-11e1-bd09-00144feabdc0</ft:uid></item><item><title>McGraw-Hill preps education auction, sources say </title><link>http://www.ft.com/cms/s/2/29e18e50-4917-11e1-88f0-00144feabdc0.html?ftcamp=rss</link><guid>http://www.ft.com/cms/s/2/29e18e50-4917-11e1-88f0-00144feabdc0.html?ftcamp=rss</guid><description>Improved debt market opens window for private equity buyers. by dealReporter
</description><pubDate>Fri, 27 Jan 2012 18:58:19 +0000</pubDate><ft:uid>29e18e50-4917-11e1-88f0-00144feabdc0</ft:uid></item><item><title>Spectrum fight in final rounds on Capitol Hill</title><link>http://www.ft.com/cms/s/2/f161d0ca-483b-11e1-b1b4-00144feabdc0.html?ftcamp=rss</link><guid>http://www.ft.com/cms/s/2/f161d0ca-483b-11e1-b1b4-00144feabdc0.html?ftcamp=rss</guid><description>Reconciling House and Senate measures in near-term, however, could be dicey. by dealReporter
</description><pubDate>Thu, 26 Jan 2012 16:49:59 +0000</pubDate><ft:uid>f161d0ca-483b-11e1-b1b4-00144feabdc0</ft:uid></item><item><title>Pfizer: Danone and Mead Johnson consider team-up for nutrition bid</title><link>http://www.ft.com/cms/s/2/fdac1f4c-482d-11e1-b1b4-00144feabdc0.html?ftcamp=rss</link><guid>http://www.ft.com/cms/s/2/fdac1f4c-482d-11e1-b1b4-00144feabdc0.html?ftcamp=rss</guid><description>Options being considered in face of antitrust concerns. by mergermarket
</description><pubDate>Thu, 26 Jan 2012 15:11:23 +0000</pubDate><ft:uid>fdac1f4c-482d-11e1-b1b4-00144feabdc0</ft:uid></item><item><title>Gilead not immune to concern over Truvada's wider HIV use</title><link>http://www.ft.com/cms/s/2/02cf7ddc-4696-11e1-89a8-00144feabdc0.html?ftcamp=rss</link><guid>http://www.ft.com/cms/s/2/02cf7ddc-4696-11e1-89a8-00144feabdc0.html?ftcamp=rss</guid><description>Drug facing hurdles for use in prevention setting. by Biopharm Insight
</description><pubDate>Tue, 24 Jan 2012 14:42:21 +0000</pubDate><ft:uid>02cf7ddc-4696-11e1-89a8-00144feabdc0</ft:uid></item><item><title>Genex Services in sale process through Bank of America</title><link>http://www.ft.com/cms/s/2/40fe13ca-4371-11e1-8489-00144feab49a.html?ftcamp=rss</link><guid>http://www.ft.com/cms/s/2/40fe13ca-4371-11e1-8489-00144feab49a.html?ftcamp=rss</guid><description>Process in early stages, with no first round bid deadline set. by mergermarket
</description><pubDate>Fri, 20 Jan 2012 14:44:23 +0000</pubDate><ft:uid>40fe13ca-4371-11e1-8489-00144feab49a</ft:uid></item><item><title>Germany's tough reimbursement rules cause drug companies to consider alternative drug trial solutions </title><link>http://www.ft.com/cms/s/2/d458d470-4696-11e1-89a8-00144feabdc0.html?ftcamp=rss</link><guid>http://www.ft.com/cms/s/2/d458d470-4696-11e1-89a8-00144feabdc0.html?ftcamp=rss</guid><description>Companies turning to data providers to obtain local outcomes data. by BioPharm Insight
</description><pubDate>Tue, 24 Jan 2012 14:42:21 +0000</pubDate><ft:uid>d458d470-4696-11e1-89a8-00144feabdc0</ft:uid></item><item><title>Novellus top convertible issuance in dealReporter poll</title><link>http://www.ft.com/cms/s/2/4339d37c-42f4-11e1-b756-00144feab49a.html?ftcamp=rss</link><guid>http://www.ft.com/cms/s/2/4339d37c-42f4-11e1-b756-00144feab49a.html?ftcamp=rss</guid><description>Offering locked in low rate, big share repurchase. by dealReporter
</description><pubDate>Thu, 19 Jan 2012 23:32:06 +0000</pubDate><ft:uid>4339d37c-42f4-11e1-b756-00144feab49a</ft:uid></item><item><title>Italy's Monti says no plans to sell government stakes in Italian companies</title><link>http://www.ft.com/cms/s/2/57f09ca6-42f4-11e1-b756-00144feab49a.html?ftcamp=rss</link><guid>http://www.ft.com/cms/s/2/57f09ca6-42f4-11e1-b756-00144feab49a.html?ftcamp=rss</guid><description>Buyer's market not conducive to monetizing valuable assets, but government has 'open mind'. by dealReporter
</description><pubDate>Thu, 19 Jan 2012 23:32:06 +0000</pubDate><ft:uid>57f09ca6-42f4-11e1-b756-00144feab49a</ft:uid></item><item><title>Erdenes Tavan Tolgoi mulls dropping Hong Kong portion of USD 3bn IPO </title><link>http://www.ft.com/cms/s/2/88f40f32-387b-11e1-9f07-00144feabdc0.html?ftcamp=rss</link><guid>http://www.ft.com/cms/s/2/88f40f32-387b-11e1-9f07-00144feabdc0.html?ftcamp=rss</guid><description>Even Hong Kong exchange sees tough sell to investors skeptical of foreign mining stocks. by dealReporter
</description><pubDate>Fri, 6 Jan 2012 21:16:01 +0000</pubDate><ft:uid>88f40f32-387b-11e1-9f07-00144feabdc0</ft:uid></item><item><title>Landmark China antitrust settlement opposed by adviser</title><link>http://www.ft.com/cms/s/2/9faeda3e-37ce-11e1-9fb0-00144feabdc0.html?ftcamp=rss</link><guid>http://www.ft.com/cms/s/2/9faeda3e-37ce-11e1-9fb0-00144feabdc0.html?ftcamp=rss</guid><description>New cases may follow if investigation not settled. by dealReporter
</description><pubDate>Thu, 5 Jan 2012 19:06:52 +0000</pubDate><ft:uid>9faeda3e-37ce-11e1-9fb0-00144feabdc0</ft:uid></item><item><title>Korean IPO resilience to continue in 2012</title><link>http://www.ft.com/cms/s/2/02dcbf92-2cb5-11e1-8cca-00144feabdc0.html?ftcamp=rss</link><guid>http://www.ft.com/cms/s/2/02dcbf92-2cb5-11e1-8cca-00144feabdc0.html?ftcamp=rss</guid><description>Samsung, LG, SK, and Lotte subsidiaries targeted by IPO arrangers. by dealReporter
</description><pubDate>Thu, 22 Dec 2011 16:04:12 +0000</pubDate><ft:uid>02dcbf92-2cb5-11e1-8cca-00144feabdc0</ft:uid></item><item><title>Drydocks World restructuring talks unlikely to be impacted by Monarch lawsuit </title><link>http://www.ft.com/cms/s/2/332e0ea4-20c5-11e1-816d-00144feabdc0.html?ftcamp=rss</link><guid>http://www.ft.com/cms/s/2/332e0ea4-20c5-11e1-816d-00144feabdc0.html?ftcamp=rss</guid><description>A judgment against Drydocks World would hold little sway in Dubai. by dealReporter
</description><pubDate>Wed, 7 Dec 2011 11:22:02 +0000</pubDate><ft:uid>332e0ea4-20c5-11e1-816d-00144feabdc0</ft:uid></item><item><title>Commercial Metals/Icahn strap in for long 'cat fight'</title><link>http://www.ft.com/cms/s/2/3190d412-1c76-11e1-9b41-00144feabdc0.html?ftcamp=rss</link><guid>http://www.ft.com/cms/s/2/3190d412-1c76-11e1-9b41-00144feabdc0.html?ftcamp=rss</guid><description>Icahn likely to lauch a tender offer, push to rescind CMC's poison pill. by dealReporter
</description><pubDate>Thu, 1 Dec 2011 23:53:25 +0000</pubDate><ft:uid>3190d412-1c76-11e1-9b41-00144feabdc0</ft:uid></item><item><title>The EC to slam Google with 400+ page SO </title><link>http://www.ft.com/cms/s/2/a6065478-1c6e-11e1-9b41-00144feabdc0.html?ftcamp=rss</link><guid>http://www.ft.com/cms/s/2/a6065478-1c6e-11e1-9b41-00144feabdc0.html?ftcamp=rss</guid><description>Eric Schmidt is expected to pay a "courtesy visit" to the Commissioner Almunia next week. by dealReporter
</description><pubDate>Thu, 1 Dec 2011 23:24:55 +0000</pubDate><ft:uid>a6065478-1c6e-11e1-9b41-00144feabdc0</ft:uid></item><item><title>Dollar Thrifty/Hertz remedy package lined up amid FTC impatience</title><link>http://www.ft.com/cms/s/2/de26d046-1ba9-11e1-8647-00144feabdc0.html?ftcamp=rss</link><guid>http://www.ft.com/cms/s/2/de26d046-1ba9-11e1-8647-00144feabdc0.html?ftcamp=rss</guid><description>Hertz presents FTC staff with a remedy package. by dealReporter
</description><pubDate>Wed, 30 Nov 2011 23:46:17 +0000</pubDate><ft:uid>de26d046-1ba9-11e1-8647-00144feabdc0</ft:uid></item><item><title>Unicredit rights offering lures underwriters despite risk</title><link>http://www.ft.com/cms/s/2/b7eefe88-1b9c-11e1-8647-00144feabdc0.html?ftcamp=rss</link><guid>http://www.ft.com/cms/s/2/b7eefe88-1b9c-11e1-8647-00144feabdc0.html?ftcamp=rss</guid><description>Unicredit prepares for EUR 7.5bn rights issue. by dealReporter
</description><pubDate>Wed, 30 Nov 2011 22:14:49 +0000</pubDate><ft:uid>b7eefe88-1b9c-11e1-8647-00144feabdc0</ft:uid></item><item><title>SonoSite bidders home in on multiple, 'call points', sources say</title><link>http://www.ft.com/cms/s/2/f7d65648-1b99-11e1-8647-00144feabdc0.html?ftcamp=rss</link><guid>http://www.ft.com/cms/s/2/f7d65648-1b99-11e1-8647-00144feabdc0.html?ftcamp=rss</guid><description>Fewer bidders pursuing SonoSite. by dealReporter
</description><pubDate>Wed, 30 Nov 2011 21:36:00 +0000</pubDate><ft:uid>f7d65648-1b99-11e1-8647-00144feabdc0</ft:uid></item><item><title>CoreLogic's complex sale process advances</title><link>http://www.ft.com/cms/s/2/fb66e9c6-1b94-11e1-8647-00144feabdc0.html?ftcamp=rss</link><guid>http://www.ft.com/cms/s/2/fb66e9c6-1b94-11e1-8647-00144feabdc0.html?ftcamp=rss</guid><description>CoreLogic collects multiple rounds of bids. by dealReporter
</description><pubDate>Wed, 30 Nov 2011 21:23:39 +0000</pubDate><ft:uid>fb66e9c6-1b94-11e1-8647-00144feabdc0</ft:uid></item><item><title>Yahoo: Microsoft signs NDA</title><link>http://www.ft.com/cms/s/2/79724bc4-15e3-11e1-8db8-00144feabdc0.html?ftcamp=rss</link><guid>http://www.ft.com/cms/s/2/79724bc4-15e3-11e1-8db8-00144feabdc0.html?ftcamp=rss</guid><description>Yahoo board to discuss recap next week. by dealReporter
</description><pubDate>Wed, 23 Nov 2011 16:08:48 +0000</pubDate><ft:uid>79724bc4-15e3-11e1-8db8-00144feabdc0</ft:uid></item><item><title>Gilead's 'big bet' on Pharmasset hinges on future results</title><link>http://www.ft.com/cms/s/2/421ff2a6-1526-11e1-855a-00144feabdc0.html?ftcamp=rss</link><guid>http://www.ft.com/cms/s/2/421ff2a6-1526-11e1-855a-00144feabdc0.html?ftcamp=rss</guid><description>Bankers question takeover premium paid for 'unapproved products'. b
y Bopharm Insight
</description><pubDate>Tue, 22 Nov 2011 16:38:15 +0000</pubDate><ft:uid>421ff2a6-1526-11e1-855a-00144feabdc0</ft:uid></item><item><title>Antitrust chiefs cite transparency, tout growing tech prowess</title><link>http://www.ft.com/cms/s/2/6b0dc60e-121d-11e1-8ab1-00144feabdc0.html?ftcamp=rss</link><guid>http://www.ft.com/cms/s/2/6b0dc60e-121d-11e1-8ab1-00144feabdc0.html?ftcamp=rss</guid><description>Investigations adequately resourced despite regional office closures. by dealReporter
</description><pubDate>Fri, 18 Nov 2011 21:24:48 +0000</pubDate><ft:uid>6b0dc60e-121d-11e1-8ab1-00144feabdc0</ft:uid></item><item><title>PepsiCo opening up to advice on alternatives, bankers say</title><link>http://www.ft.com/cms/s/2/c14450ce-1056-11e1-8211-00144feabdc0.html?ftcamp=rss</link><guid>http://www.ft.com/cms/s/2/c14450ce-1056-11e1-8211-00144feabdc0.html?ftcamp=rss</guid><description>Company could split along geographic lines. by dealReporter
</description><pubDate>Wed, 16 Nov 2011 13:30:34 +0000</pubDate><ft:uid>c14450ce-1056-11e1-8211-00144feabdc0</ft:uid></item><item><title>Computer Sciences activist shake-up chatter heats up</title><link>http://www.ft.com/cms/s/2/4d88de62-0f8d-11e1-88cc-00144feabdc0.html?ftcamp=rss</link><guid>http://www.ft.com/cms/s/2/4d88de62-0f8d-11e1-88cc-00144feabdc0.html?ftcamp=rss</guid><description>Unclear if pressure will result in strategic review. by dealReporter
</description><pubDate>Tue, 15 Nov 2011 13:33:50 +0000</pubDate><ft:uid>4d88de62-0f8d-11e1-88cc-00144feabdc0</ft:uid></item><item><title>China sets antitrust milestone with investigation into large SOEs </title><link>http://www.ft.com/cms/s/2/94fc97c6-0f73-11e1-88cc-00144feabdc0.html?ftcamp=rss</link><guid>http://www.ft.com/cms/s/2/94fc97c6-0f73-11e1-88cc-00144feabdc0.html?ftcamp=rss</guid><description>US has been pressuring China to enforce regulations. by dealReporter
</description><pubDate>Tue, 15 Nov 2011 10:32:44 +0000</pubDate><ft:uid>94fc97c6-0f73-11e1-88cc-00144feabdc0</ft:uid></item><item><title>Mongolia dealmakers see strong pipeline</title><link>http://www.ft.com/cms/s/2/b974c4ca-0f73-11e1-88cc-00144feabdc0.html?ftcamp=rss</link><guid>http://www.ft.com/cms/s/2/b974c4ca-0f73-11e1-88cc-00144feabdc0.html?ftcamp=rss</guid><description>Hurdles over valuation. by mergermarket
</description><pubDate>Tue, 15 Nov 2011 10:32:44 +0000</pubDate><ft:uid>b974c4ca-0f73-11e1-88cc-00144feabdc0</ft:uid></item><item><title>Alibaba driving 'fluid' Yahoo process</title><link>http://www.ft.com/cms/s/2/9f199e70-0f73-11e1-88cc-00144feabdc0.html?ftcamp=rss</link><guid>http://www.ft.com/cms/s/2/9f199e70-0f73-11e1-88cc-00144feabdc0.html?ftcamp=rss</guid><description>Sale of entire company seen as favored approach. by dealReporter
</description><pubDate>Tue, 15 Nov 2011 10:32:44 +0000</pubDate><ft:uid>9f199e70-0f73-11e1-88cc-00144feabdc0</ft:uid></item><item><title>GST Autoleather's USD 135m refinancing led by ING Bank stalls</title><link>http://www.ft.com/cms/s/2/2286a834-0c4a-11e1-8ac6-00144feabdc0.html?ftcamp=rss</link><guid>http://www.ft.com/cms/s/2/2286a834-0c4a-11e1-8ac6-00144feabdc0.html?ftcamp=rss</guid><description>Auto leather seatmaker bridged by USD 20m injection by hedge fund and USD 15m factoring line. by Debtwire
</description><pubDate>Fri, 11 Nov 2011 09:51:23 +0000</pubDate><ft:uid>2286a834-0c4a-11e1-8ac6-00144feabdc0</ft:uid></item><item><title>Pacific Life spurs possible trade finance sea change</title><link>http://www.ft.com/cms/s/2/07a72fec-0bf6-11e1-9310-00144feabdc0.html?ftcamp=rss</link><guid>http://www.ft.com/cms/s/2/07a72fec-0bf6-11e1-9310-00144feabdc0.html?ftcamp=rss</guid><description>Guidelines establishing insurers as major trade finance investors in the works. by mergermarket
</description><pubDate>Fri, 11 Nov 2011 00:26:57 +0000</pubDate><ft:uid>07a72fec-0bf6-11e1-9310-00144feabdc0</ft:uid></item><item><title>Unilever exploring options to restructure food business</title><link>http://www.ft.com/cms/s/2/1a038836-0bb8-11e1-9310-00144feabdc0.html?ftcamp=rss</link><guid>http://www.ft.com/cms/s/2/1a038836-0bb8-11e1-9310-00144feabdc0.html?ftcamp=rss</guid><description>Consumer giant evaluating low-margin units. by mergermarket
</description><pubDate>Thu, 10 Nov 2011 16:34:56 +0000</pubDate><ft:uid>1a038836-0bb8-11e1-9310-00144feabdc0</ft:uid></item><item><title>China VIE structure may hold hidden risks </title><link>http://www.ft.com/cms/s/2/0a1e4d78-0bf6-11e1-9310-00144feabdc0.html?ftcamp=rss</link><guid>http://www.ft.com/cms/s/2/0a1e4d78-0bf6-11e1-9310-00144feabdc0.html?ftcamp=rss</guid><description>Little regulatory consensus on how to regulate. by dealReporter
</description><pubDate>Fri, 11 Nov 2011 00:27:14 +0000</pubDate><ft:uid>0a1e4d78-0bf6-11e1-9310-00144feabdc0</ft:uid></item><item><title>Cytec stripped of Coating Resins becomes takeout prey</title><link>http://www.ft.com/cms/s/2/4084d56c-0bf6-11e1-9310-00144feabdc0.html?ftcamp=rss</link><guid>http://www.ft.com/cms/s/2/4084d56c-0bf6-11e1-9310-00144feabdc0.html?ftcamp=rss</guid><description>Bankers say pure play composites business could attract GE, Honeywell, 3M. by dealReporter
</description><pubDate>Fri, 11 Nov 2011 00:27:14 +0000</pubDate><ft:uid>4084d56c-0bf6-11e1-9310-00144feabdc0</ft:uid></item><item><title>Federated Investors pitching trade finance strategy</title><link>http://www.ft.com/cms/s/2/5d4eb7ec-0991-11e1-a2bb-00144feabdc0.html?ftcamp=rss</link><guid>http://www.ft.com/cms/s/2/5d4eb7ec-0991-11e1-a2bb-00144feabdc0.html?ftcamp=rss</guid><description>Specter of regulatory-driven constraints hang over traditional lending. by mergermarket
</description><pubDate>Mon, 7 Nov 2011 22:55:57 +0000</pubDate><ft:uid>5d4eb7ec-0991-11e1-a2bb-00144feabdc0</ft:uid></item><item><title>MedoCo/Express Scripts AG investigators list revealed</title><link>http://www.ft.com/cms/s/2/edb6cf16-0731-11e1-8ccb-00144feabdc0.html?ftcamp=rss</link><guid>http://www.ft.com/cms/s/2/edb6cf16-0731-11e1-8ccb-00144feabdc0.html?ftcamp=rss</guid><description>Full list of states involved in the coalition of attorney generals revealed. by dealReporter
</description><pubDate>Fri, 4 Nov 2011 22:20:50 +0000</pubDate><ft:uid>edb6cf16-0731-11e1-8ccb-00144feabdc0</ft:uid></item><item><title>US rare earths miners would benefit from proposed stockpile</title><link>http://www.ft.com/cms/s/2/0982794e-06e6-11e1-b9cc-00144feabdc0.html?ftcamp=rss</link><guid>http://www.ft.com/cms/s/2/0982794e-06e6-11e1-b9cc-00144feabdc0.html?ftcamp=rss</guid><description>US rare earth strategic reserve more likely following Chinese production halt. by dealReporter
</description><pubDate>Fri, 4 Nov 2011 13:30:54 +0000</pubDate><ft:uid>0982794e-06e6-11e1-b9cc-00144feabdc0</ft:uid></item><item><title>European financial crisis opens door to investment from cash-rich Japanese suitors</title><link>http://www.ft.com/cms/s/2/9276b8ba-06ea-11e1-b9cc-00144feabdc0.html?ftcamp=rss</link><guid>http://www.ft.com/cms/s/2/9276b8ba-06ea-11e1-b9cc-00144feabdc0.html?ftcamp=rss</guid><description>Japanese companies are keener than ever to expand outside their domestic sphere. by mergermarket
</description><pubDate>Fri, 4 Nov 2011 13:45:11 +0000</pubDate><ft:uid>9276b8ba-06ea-11e1-b9cc-00144feabdc0</ft:uid></item><item><title>Cambridge Major Laboratories in sale process</title><link>http://www.ft.com/cms/s/2/d8a7d63e-0591-11e1-8eaa-00144feabdc0.html?ftcamp=rss</link><guid>http://www.ft.com/cms/s/2/d8a7d63e-0591-11e1-8eaa-00144feabdc0.html?ftcamp=rss</guid><description>Contract research company retains Jefferies. by mergermarket
</description><pubDate>Wed, 2 Nov 2011 20:54:07 +0000</pubDate><ft:uid>d8a7d63e-0591-11e1-8eaa-00144feabdc0</ft:uid></item><item><title>All Metro Health Care Services retains bank to advise on sale</title><link>http://www.ft.com/cms/s/2/4c596f02-0592-11e1-8eaa-00144feabdc0.html?ftcamp=rss</link><guid>http://www.ft.com/cms/s/2/4c596f02-0592-11e1-8eaa-00144feabdc0.html?ftcamp=rss</guid><description>Brown Brothers Harriman portfolio company advised by Lazard. by mergermarket
</description><pubDate>Wed, 2 Nov 2011 20:54:07 +0000</pubDate><ft:uid>4c596f02-0592-11e1-8eaa-00144feabdc0</ft:uid></item><item><title>ITT Exelis takeover debate emerges post spin-off</title><link>http://www.ft.com/cms/s/2/50987086-04b6-11e1-91d9-00144feabdc0.html?ftcamp=rss</link><guid>http://www.ft.com/cms/s/2/50987086-04b6-11e1-91d9-00144feabdc0.html?ftcamp=rss</guid><description>Suitors may want to see trading, defense budget. by dealReporter
</description><pubDate>Tue, 1 Nov 2011 19:35:08 +0000</pubDate><ft:uid>50987086-04b6-11e1-91d9-00144feabdc0</ft:uid></item><item><title>Egyptian PPP outlook positive despite of financing challenges</title><link>http://www.ft.com/cms/s/2/5376228a-04b6-11e1-91d9-00144feabdc0.html?ftcamp=rss</link><guid>http://www.ft.com/cms/s/2/5376228a-04b6-11e1-91d9-00144feabdc0.html?ftcamp=rss</guid><description>Egyptian government and international investors grapple with currency issues. by mergermarket
</description><pubDate>Tue, 1 Nov 2011 19:34:43 +0000</pubDate><ft:uid>5376228a-04b6-11e1-91d9-00144feabdc0</ft:uid></item><item><title>Specter of politicized regulators looms over Yum! Brands' Chinese takeover bid </title><link>http://www.ft.com/cms/s/2/df616814-01a9-11e1-8e59-00144feabdc0.html?ftcamp=rss</link><guid>http://www.ft.com/cms/s/2/df616814-01a9-11e1-8e59-00144feabdc0.html?ftcamp=rss</guid><description>Sino-US trade friction seen affecting deal's MOFCOM review of Little Sheep takeover. by dealReporter
</description><pubDate>Fri, 28 Oct 2011 23:08:30 +0100</pubDate><ft:uid>df616814-01a9-11e1-8e59-00144feabdc0</ft:uid></item><item><title>Feared trade finance squeeze compels bankers to explore alternatives</title><link>http://www.ft.com/cms/s/2/11c1a5f2-01ab-11e1-8e59-00144feabdc0.html?ftcamp=rss</link><guid>http://www.ft.com/cms/s/2/11c1a5f2-01ab-11e1-8e59-00144feabdc0.html?ftcamp=rss</guid><description>Obama's bold export plans encounter regulatory-induced financing constraints. by mergermarket
</description><pubDate>Fri, 28 Oct 2011 23:07:54 +0100</pubDate><ft:uid>11c1a5f2-01ab-11e1-8e59-00144feabdc0</ft:uid></item><item><title>Price Pfister in late stages of sale process with UBS</title><link>http://www.ft.com/cms/s/2/ab1bc60a-ff4f-11e0-aa11-00144feabdc0.html?ftcamp=rss</link><guid>http://www.ft.com/cms/s/2/ab1bc60a-ff4f-11e0-aa11-00144feabdc0.html?ftcamp=rss</guid><description>Source says PE buyers and foreign strategics interested. by mergermarket
</description><pubDate>Tue, 25 Oct 2011 22:30:52 +0100</pubDate><ft:uid>ab1bc60a-ff4f-11e0-aa11-00144feabdc0</ft:uid></item><item><title>Olympus likely to face shareholder legal backlash</title><link>http://www.ft.com/cms/s/2/a1eeaf14-fe61-11e0-a72c-00144feabdc0.html?ftcamp=rss</link><guid>http://www.ft.com/cms/s/2/a1eeaf14-fe61-11e0-a72c-00144feabdc0.html?ftcamp=rss</guid><description>Register contains several large overseas investors, including Southeastern Asset Management and the Government of Singapore. by dealReporter
</description><pubDate>Mon, 24 Oct 2011 18:11:19 +0100</pubDate><ft:uid>a1eeaf14-fe61-11e0-a72c-00144feabdc0</ft:uid></item><item><title>Harvard Bioscience in sale process</title><link>http://www.ft.com/cms/s/2/6a61d61e-fbf7-11e0-b1d8-00144feab49a.html?ftcamp=rss</link><guid>http://www.ft.com/cms/s/2/6a61d61e-fbf7-11e0-b1d8-00144feab49a.html?ftcamp=rss</guid><description>Sources say Euroconsult advising. by dealReporter
</description><pubDate>Fri, 21 Oct 2011 16:27:49 +0100</pubDate><ft:uid>6a61d61e-fbf7-11e0-b1d8-00144feab49a</ft:uid></item><item><title>Japan Inc to continue appointing foreign CEOs </title><link>http://www.ft.com/cms/s/2/b62bbfc2-fb1d-11e0-bebe-00144feab49a.html?ftcamp=rss</link><guid>http://www.ft.com/cms/s/2/b62bbfc2-fb1d-11e0-bebe-00144feab49a.html?ftcamp=rss</guid><description>Trend likely to continue as part of overseas growth strategy by mergermarket
</description><pubDate>Thu, 20 Oct 2011 14:29:16 +0100</pubDate><ft:uid>b62bbfc2-fb1d-11e0-bebe-00144feab49a</ft:uid></item></channel></rss>






    



